Status:
COMPLETED
Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
Lead Sponsor:
Abbott
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The objective is to measure time delay from onset of symptoms to diagnosis and time to disease-modifying anti-rheumatic drug treatments in Turkish patients with rheumatoid arthritis. The investigators...
Detailed Description
This post marketing observational study will be conducted in cross-sectional, non-interventional, multi-center format in Turkey. As this is a post marketing observational study, Abbott is not involved...
Eligibility Criteria
Inclusion
- Diagnosed with rheumatoid arthritis by a specialist or by the treating rheumatologist
- Treated with at least one disease-modifying anti-rheumatic drug or biologics
- Patients over 18 years
- Patients already employed at a paid work
- Patients able to provide data for disease history
- Able to provide written consent to release information for this study
Exclusion
- Patients who cannot provide necessary outcome measurements for any reason will be excluded from the study
Key Trial Info
Start Date :
February 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
356 Patients enrolled
Trial Details
Trial ID
NCT01144598
Start Date
February 1 2010
End Date
August 1 2011
Last Update
October 2 2012
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 39111
Adana, Turkey (Türkiye), 01330
2
Site Reference ID/Investigator# 39102
Ankara, Turkey (Türkiye), 06018
3
Site Reference ID/Investigator# 39104
Ankara, Turkey (Türkiye), 06100
4
Site Reference ID/Investigator# 39109
Ankara, Turkey (Türkiye), 06100